How confident are you in assessing fatty liver with ultrasound?
Web version

Canon Medical Systems USA
Made for Life
Take the uncertainty out of fatty liver assessment
Download the whitepaper to see Attenuation Imaging in action. »
With approximately 100 million people in the U.S. diagnosed with Nonalcoholic Fatty Liver Disease (NAFLD)*, you need a fast, quantitative way to evaluate the disease's progression in your patients. Canon Medical's Attenuation Imaging (ATI) can help. It is the first-of-its-kind ultrasound technology that makes assessing the markers of fatty liver objective by providing an attenuation coefficient that increases as the amount of fat goes up.

ATI helps you better assess fat levels:
Quickly and easily: With just the click of a button, sonographers can capture the quantitative data that radiologists need for assessment.
With certainty: Color codes and measurable data can help you determine whether or not fat is increasing.
In more patients: Canon Medical extends this technology to multiple lines of its ultrasound systems.
Confidently monitor your liver patients with Attenuation Imaging from Canon Medical.
*American Liver Foundation: h‌ttps://, September 2020
Download the whitepaper to see Attenuation Imaging in action. »
Collaborative Imaging - Made for Life
Sign up here to stay up to date with the latest Canon Medical Systems USA, Inc. news.
©Canon Medical Systems USA, Inc. 2020. All rights reserved. Design and specifications are subject to change without notice.
 Do not reply to this email as it was sent from an unmonitored account.
Unsubscribe from the Ultrasound Insider.
Reset your password.
Contact support. Privacy Policy
Email sent to: ., 1350 North Kolb Road, Suite 215, Tucson, AZ 85715 USA - (520) 298-1000